Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Seven Clinical Trial Read-Outs Due In Q4

Oct 11 2017

• By Alex Shimmings

Testing — Clinical Trial Read-Outs • Source: Shutterstock

Related Content

Cytokinetics plunges as tirasemtiv fails to BENEFIT-ALS

Apr 26 2014

Patient Death Casts Cloud Over Roche Emicizumab Hemophilia Trial

Feb 24 2017

Cytokinetics Seeks ALS Success By Focusing On Lung Function

Aug 19 2016

Catalyst Collapses On FDA Firdapse Refusal

Feb 18 2016

Roche's Emicizumab Progresses Against Hemophilia's Next Big Challenge: Patients With Factor VIII Inhibitors

Apr 18 2017

Disappointed, Yes, But Roivant's Not Roiled By Axovant's Alzheimer's Failure

Sep 27 2017

Phase III Updates Bode Well For Filings Of Roche's Emicizumab In Hemophilia

Jul 11 2017

Related Companies

Astellas Pharma, Inc.

Cytokinetics, Inc.

Sio Gene Therapies, Inc.

Roche Holding AG

Ardelyx Inc.

Catalyst Pharmaceuticals, Inc.

Galectin Therapeutics Inc.

Atlantic Healthcare plc

Additional Topics

Clinical Trials Research & Development Metabolic Disorders Blood & Coagulation Disorders Neurology Inflammation Gastrointestinal BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window